Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L'Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell ...
UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine in children and adults with CDKL5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback